13.75 USD
↘ 0.05 (0.33%)LIVE (AS OF 12:55 PM EDT)
InMode Ltd. Ordinary Shares
INMDNASDAQ • USD
Market: OPEN
Open?$13.79
High?$13.86
Low?$13.64
Prev. Close?$13.79
Volume?124.1K
Avg. Volume?1.0M
VWAP?$13.78
Rel. Volume?0.12x
Bid / Ask
Bid?$13.74 × 300
Ask?$13.76 × 300
Spread?$0.02
Midpoint?$13.75
Valuation & Ratios
Market Cap?873.7M
Shares Out?63.4M
Float?56.5M
Float %?89.2%
P/E Ratio?9.17
P/B Ratio?2.97
EPS?$1.50
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?7.65Strong
Quick Ratio?7.22Strong
Cash Ratio?1.77Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score89/100
P/E?9.2CHEAP▾
P/B?2.97CHEAP▾
P/S?3.78FAIR▾
P/FCF?9.0CHEAP▾
EV/EBITDA?8.6CHEAP▾
EV/Sales?3.50FAIR▾
Returns & Efficiency
ROE?32.4%STRONG▾
ROA?28.2%STRONG▾
Cash Flow & Enterprise
FCF?$97.3M
Enterprise Value?$808.8M
Related Companies
Loading...
News
Profile
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.